| Name | Title | Contact Details |
|---|---|---|
Christopher Prentiss |
Chief Financial Officer | Profile |
Tanya Booke |
Head of Talent Management and Culture | Profile |
Johanna Ulloa |
Director Clinical Development, R&D | Profile |
Christopher Klatka |
Head of Talent Acquisition | Profile |
Chris Lewallyn |
Head Total Rewards and Human Resource Operations | Profile |
Talaris Therapeutics is a late-clinical stage biotechnology company based in Boston, MA and Louisville, KY. Talaris is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe auto-immune and immune-mediated disorders. The company was founded on technology discovered and developed by Dr. Suzanne Ildstad and operates its own cell processing facility in Louisville. Talaris is backed by leading life sciences investors Blackstone Life Sciences, Longitude Capital and Qiming Venture Partners USA.
Endobiologics is a Missoula, MT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Renovacor is a preclinical gene therapy company developing a pipeline of innovative and proprietary AAV based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Renovacor`s therapeutic focus is initially on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.
Carolus Therapeutics is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MedXcel is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.